The Pheo Para Alliance’s Scan of Pheochromocytoma & Paraganglioma (PPGL) Experiences (SCOPPE Survey 2.0) study is CLOSED.
According to the PPA’s Study Lead, Dr. Fishbein, well over 200 responses were received. This survey was distributed only in the United States and Canada.
On behalf of the PPA, thank you for completing the survey and encouraging others to contribute to a better understanding of the quality of life for people living with PPGL.
We encourage you to learn about SCOPPE Survey 1.0 and its findings. As soon as it’s ready, we will share findings from the SCOPPE Survey 2.0!